BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6428688)

  • 1. Evaluation of a gluten free product containing wheat gliadin in patients with coeliac disease.
    Ciclitira PJ; Ellis HJ; Fagg NL
    Br Med J (Clin Res Ed); 1984 Jul; 289(6437):83. PubMed ID: 6428688
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-specific cytotoxicity of wheat gliadin components towards cultured human cells.
    Hudson DA; Cornell HJ; Purdham DR; Rolles CJ
    Lancet; 1976 Feb; 1(7955):339-41. PubMed ID: 54743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.
    Pizzuti D; Buda A; D'Odorico A; D'IncĂ  R; Chiarelli S; Curioni A; Martines D
    Scand J Gastroenterol; 2006 Nov; 41(11):1305-11. PubMed ID: 17060124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of gliadin in coeliac patients.
    Patey AL
    Lancet; 1980 Aug; 2(8191):427-8. PubMed ID: 6105547
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of gliadin-derived peptides from bread and durum wheats on in vitro cultures of human cell lines. Implications for coeliac disease pathogenesis.
    Rocca E; Paganuzzi Stammati A; Zampaglioni F; Zucco F
    Toxicol Lett; 1983 May; 16(3-4):331-8. PubMed ID: 6857727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a gliadin-containing gluten-free product in coeliac patients.
    Ciclitira PJ; Cerio R; Ellis HJ; Maxton D; Nelufer JM; Macartney JM
    Hum Nutr Clin Nutr; 1985 Jul; 39(4):303-8. PubMed ID: 3930437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical testing of bread made from nullisomic 6A wheats in coeliac patients.
    Ciclitira PJ; Hunter JO; Lennox ES
    Lancet; 1980 Aug; 2(8188):234-6. PubMed ID: 6105397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins.
    Howdle PD; Ciclitira PJ; Simpson FG; Losowsky MS
    Scand J Gastroenterol; 1984 Jan; 19(1):41-7. PubMed ID: 6710076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical testing of gliadin fractions in coeliac patients.
    Ciclitira PJ; Evans DJ; Fagg NL; Lennox ES; Dowling RH
    Clin Sci (Lond); 1984 Mar; 66(3):357-64. PubMed ID: 6692666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radioimmunoassay for wheat gliadin to assess the suitability of gluten free foods for patients with coeliac disease.
    Ciclitira PJ; Ellis HJ; Evans DJ; Lennox ES
    Clin Exp Immunol; 1985 Mar; 59(3):703-8. PubMed ID: 3987095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of different wheat gliadins in coeliac disease.
    Wieser H; Springer G; Belitz HD; Ashkenazi A; Idar D
    Z Lebensm Unters Forsch; 1982; 175(5):321-6. PubMed ID: 6758408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Decrease of the cytotoxicity of gliadin fractions in the development of celiac disease. Organotypic culture study].
    Arnaud-Battandier F; Magazzu G; Schmitz J; Jos J; Rey J
    Arch Fr Pediatr; 1985 Mar; 42(3):245-8. PubMed ID: 4004485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wheat deficient in gliadins: promising tool for treatment of coeliac disease.
    Frisoni M; Corazza GR; Lafiandra D; De Ambrogio E; Filipponi C; Bonvicini F; Borasio E; Porceddu E; Gasbarrini G
    Gut; 1995 Mar; 36(3):375-8. PubMed ID: 7698695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spelt wheat and celiac disease].
    Forssell F; Wieser H
    Z Lebensm Unters Forsch; 1995 Jul; 201(1):35-9. PubMed ID: 7571865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gliadin-derived peptides from bread and durum wheats on small intestine cultures from rat fetus and coeliac children.
    Auricchio S; De Ritis G; De Vincenzi M; Occorsio P; Silano V
    Pediatr Res; 1982 Dec; 16(12):1004-10. PubMed ID: 7155669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of immunogenicity of hydrolysed wheat flour in patients with coeliac disease after a short-term oral challenge.
    Mandile R; Picascia S; Parrella C; Camarca A; Gobbetti M; Greco L; Troncone R; Gianfrani C; Auricchio R
    Aliment Pharmacol Ther; 2017 Aug; 46(4):440-446. PubMed ID: 28627070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients.
    Spaenij-Dekking L; Kooy-Winkelaar Y; van Veelen P; Drijfhout JW; Jonker H; van Soest L; Smulders MJ; Bosch D; Gilissen LJ; Koning F
    Gastroenterology; 2005 Sep; 129(3):797-806. PubMed ID: 16143119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma.
    O'Farrelly C; Feighery C; O'Briain DS; Stevens F; Connolly CE; McCarthy C; Weir DG
    Br Med J (Clin Res Ed); 1986 Oct; 293(6552):908-10. PubMed ID: 3094712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease.
    Rivabene R; Mancini E; De Vincenzi M
    Biochim Biophys Acta; 1999 Jan; 1453(1):152-60. PubMed ID: 9989255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Facts about gluten.
    Lancet; 1975 Nov; 2(7944):1081. PubMed ID: 53562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.